Loading organizations...
§ Private Profile · 48 Wall St, New York, NY 10005, USA
Creator of immersive experiums and culture-shifting attractions, offering design, development, and operations for experiential entertainment partners.
Figure8 is an experiential entertainment company that designs, develops, and operates immersive physical spaces, operating from an undisclosed headquarters location. The organization focuses on creating large-scale attractions, referred to as experiums, which are designed to encourage visitors to disconnect from digital technology and engage with physical environments. Operating as a parent company, Figure8 manages recognizable consumer brands including the Museum of Ice Cream and Home Quart, while providing consultancy, marketing, and event activation services to external partners. The enterprise is expanding its physical footprint across the United States, with at least two new permanent locations scheduled to open in Miami and Boston throughout the 2024 calendar year. Specific corporate metrics such as total funding raised, enterprise valuation, and employee count remain undisclosed, and the organization's exact founding year and original founders are not publicly listed.
Figure8 has raised $40.0M across 1 funding round.
Figure8 has raised $40.0M in total across 1 funding round.
Figure8 has raised $40.0M across 1 funding round. Most recently, it raised $40.0M Series A in August 2019.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 1, 2019 | $40M Series A | William McClelland, Frederic Mayerson | Grace Beauty Capital, Whitney Wolfe Herd, OCV Partners | Announced |
Figure8 has raised $40.0M in total across 1 funding round.
Figure8's investors include William McClelland, Frederic Mayerson, Grace Beauty Capital, Whitney Wolfe Herd, OCV Partners.
Figure8 refers to multiple distinct technology-related entities, but based on your query and the most relevant information, there are two primary companies named Figure Eight/Figur8 with different focuses:
---
1. Figure Eight (formerly CrowdFlower)Figure Eight is a technology company specializing in machine learning data annotation. It provides a platform that transforms text, image, audio, and video data into high-quality training data for AI models. Its services support applications such as autonomous vehicles, natural language processing, search relevance, and intelligent chatbots. The company serves AI teams and enterprises needing accurate labeled data to train machine learning algorithms. It was acquired by Appen in 2019, reflecting strong growth momentum in the AI data services sector[1][2].
2. FIGUR8 (Musculoskeletal Health Tech)FIGUR8 is a healthcare technology company that builds an FDA-registered musculoskeletal (MSK) assessment platform using on-body sensors and cloud analytics. It serves clinicians, payers, and patients by providing objective, precise biomechanical data to improve injury diagnosis, treatment, and recovery outcomes. FIGUR8 addresses the problem of subjective and imprecise MSK assessments, offering a practical tool for every point of care. The company is growing by innovating in digital health and workers’ compensation claims management[4][5].
---
Figure Eight (CrowdFlower)Founded in 2007 as Dolores Labs by Lukas Biewald and Chris Van Pelt, the company emerged from experiments using crowdsourcing (Amazon Mechanical Turk) to perform simple tasks like image annotation that machines could not yet automate. Early traction came from collecting millions of human assessments for various clients, leading to the development of a scalable platform for training AI. The company rebranded to Figure Eight and expanded internationally before being acquired by Appen in 2019[2].
FIGUR8FIGUR8 began as a collaboration between MIT scientists, Massachusetts General Hospital Orthopaedics, and the Boston Red Sox, aiming to improve injury diagnosis and treatment. Founded by Nan-Wei Gong, Ph.D., an MIT graduate and serial entrepreneur, FIGUR8 developed a novel FDA-registered platform for objective MSK health assessment. The company leverages deep expertise in biomechanics and wearable technology, with early validation from clinical and sports medicine partners[4].
---
Figure Eight (CrowdFlower)- Human-in-the-loop machine learning: Combines human intelligence with AI to produce high-quality labeled data.- Scalability: Platform supports large-scale data annotation across multiple data types (text, image, audio, video).- Integration: Used in diverse AI applications including autonomous vehicles and chatbots.- Strong investor backing and acquisition: Raised nearly $56M before acquisition by Appen, indicating strong market validation[1][2].
FIGUR8- FDA-registered platform: First accurate, objective MSK assessment tool practical for widespread clinical use.- On-body sensor technology + cloud analytics: Provides real-time, lab-grade biomechanical data.- Improves clinical decision-making: Enables personalized care pathways and better outcomes.- Industry partnerships: Collaborations with MIT, hospitals, and sports teams enhance credibility and innovation[4][5].
---
Figure Eight (CrowdFlower) rides the trend of AI and machine learning growth, addressing the critical bottleneck of obtaining high-quality labeled data for training models. As AI adoption accelerates across industries, the demand for scalable, accurate data annotation platforms grows. The timing was crucial as AI matured and required more sophisticated training data, positioning Figure Eight as a key enabler in the AI ecosystem[1][2].
FIGUR8 is positioned at the intersection of digital health, wearable technology, and precision medicine. The rising focus on objective health measurements, especially in musculoskeletal care and workers’ compensation, creates a favorable market environment. FIGUR8’s technology addresses long-standing gaps in MSK injury assessment, aligning with broader healthcare trends toward data-driven, personalized care and cost reduction[4][5].
---
Figure Eight (CrowdFlower), now part of Appen, will likely continue to evolve as a backbone data annotation service supporting the expanding AI market. Trends such as generative AI and autonomous systems will increase demand for diverse, high-quality training data, sustaining growth and innovation in this space.
FIGUR8 is poised to expand its influence in healthcare by broadening adoption of its MSK assessment platform across clinical and insurance settings. Future trends in telehealth, wearable sensors, and AI-driven diagnostics will shape its journey, potentially transforming musculoskeletal care and claims management globally.
Both companies illustrate how specialized technology platforms can address critical needs in AI and healthcare, respectively, underscoring the importance of precision data and objective measurement in modern tech ecosystems.
---
If you want a detailed profile on one specific Figure8 entity, please specify which one.